Talquetamab vs real-world physicians choice of therapy (RWPC): comparative efficacy in patients (pts) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要